↓ Skip to main content

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

Overview of attention for article published in Radiation Oncology, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
Published in
Radiation Oncology, June 2012
DOI 10.1186/1748-717x-7-82
Pubmed ID
Authors

Jeffrey Vainshtein, Eyad Abu-Isa, Karin B Olson, Michael E Ray, Howard M Sandler, Dan Normolle, Dale W Litzenberg, Kathryn Masi, Charlie Pan, Daniel A Hamstra

Abstract

Low-risk prostate cancer (PCa) patients have excellent outcomes, with treatment modality often selected by perceived effects on quality of life. Acute urinary symptoms are common during external beam radiotherapy (EBRT), while chronic symptoms have been linked to urethral dose. Since most low-risk PCa occurs in the peripheral zone (PZ), we hypothesized that EBRT using urethral sparing intensity modulated radiation therapy (US-IMRT) could improve urinary health-related quality of life (HRQOL) while maintaining high rates of PCa control.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 69 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 22%
Student > Master 9 13%
Professor > Associate Professor 8 12%
Student > Doctoral Student 7 10%
Student > Postgraduate 5 7%
Other 13 19%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 36 52%
Physics and Astronomy 5 7%
Computer Science 3 4%
Agricultural and Biological Sciences 1 1%
Immunology and Microbiology 1 1%
Other 5 7%
Unknown 18 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2021.
All research outputs
#4,544,784
of 22,668,244 outputs
Outputs from Radiation Oncology
#177
of 2,044 outputs
Outputs of similar age
#31,861
of 166,771 outputs
Outputs of similar age from Radiation Oncology
#1
of 29 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,044 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,771 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.